Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?
Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) offers a low-cost, domestically focused portfolio, whereas iShares Global Healthcare ETF…
Health Canada Approves Zepbound for OSA in Adults With Obesity
Key takeaways: Health Canada approved Zepbound (tirzepatide injection) for adults with obesity and moderate to severe OSA. In…
The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch
Investors looking to capitalize on the rapidly growing artificial intelligence (AI) industry tend to turn toward leading tech…
3 Reasons to Buy Eli Lilly Stock
Eli Lilly (NYSE: LLY) has been firing on all cylinders. The stock is up 40% over the past…
Novo Nordisk moves to launch Wegovy tablet in China
Novo Nordisk plans to seek approval in China for an oral Wegovy weight-loss pill as competition with Eli…
Scott Galloway says GLP-1 drugs are a ‘silver bullet’ for America’s woes, if we’re not ‘stupid enough’ to get in the way
On June 12, SpaceX (NASDAQ: SPCX) had the biggest IPO on record, making $75 billion (1) — but…
Warning issued over counterfeit weight-loss drugs labelled as retatrutide
Senior doctors from a hospital in Melbourne’s north are warning people against taking drugs being labelled as experimental…
The Latest Ozempic Side Effect? It May Make You Less Violent
Topline GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent criminal behavior among current users,…
Novo Nordisk comeback stirs as Wegovy pill wins UK approval
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another…
New Weight Loss Drug Could Beat Ozempic’s Results—When It’s Coming
A new experimental weight loss drug from Eli Lilly could produce greater weight loss results than popular medications…
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
The global geopolitical landscape has plunged into a deep state of uncertainty once again following a direct exchange…
Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?
Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…